APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sotalol

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sotalol Market Outlook and Growth Opportunities 2026

21 December 2025199 pages

Choose your research edition.

Industry ResearchSotalol Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Sotalol Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Sotalol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sotalol Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Sotalol Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Sotalol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sotalol market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sotalol market include Shaanxi Hanjiang Pharmaceutical Group, GSK, Bayer, Samarth Pharma Pvt. Ltd., Cipla Limited, Cambrex, Bristol-Myers Squibb (BMS), Arevipharma and Arbor Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sotalol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sotalol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sotalol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sotalol market size, projected growth trends, production technologies, key applications, and end-use industries.

Sotalol Segment by Company

Shaanxi Hanjiang Pharmaceutical Group

GSK

Bayer

Samarth Pharma Pvt. Ltd.

Cipla Limited

Cambrex

Bristol-Myers Squibb (BMS)

Arevipharma

Arbor Pharmaceuticals

Sotalol Segment by Type

40mg Sotalol

80mg Sotalol

Sotalol Segment by Application

Sustained Ventricular Tachycardia

Atrial Fibrillation/Flutter

Sotalol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sotalol status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sotalol market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sotalol significant trends, drivers, influence factors in global and regions.

6. To analyze Sotalol competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotalol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sotalol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotalol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sotalol market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sotalol industry.

Chapter 3: Detailed analysis of Sotalol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sotalol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sotalol in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sotalol Industry Trends Table 2. Sotalol Industry Drivers Table 3. Sotalol Industry Opportunities and Challenges Table 4. Sotalol Industry Restraints Table 5. Global Sotalol Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sotalol Revenue Share by Company (2021-2026) Table 7. Global Sotalol Sales Volume by Company (m units) & (2021-2026) Table 8. Global Sotalol Sales Volume Share by Company (2021-2026) Table 9. Global Sotalol Average Price (US$/k unit) of Company (2021-2026) Table 10. Global Sotalol Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sotalol Key Company Manufacturing Base & Headquarters Table 12. Global Sotalol Company, Product Type & Application Table 13. Global Sotalol Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sotalol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 40mg Sotalol Table 18. Significant Companies of 80mg Sotalol Table 19. Global Sotalol Sales Volume by Type 2021 VS 2025 VS 2032 (m units) Table 20. Global Sotalol Sales Volume by Type (2021-2026) & (m units) Table 21. Global Sotalol Sales Volume by Type (2027-2032) & (m units) Table 22. Global Sotalol Sales Volume Share by Type (2021-2026) Table 23. Global Sotalol Sales Volume Share by Type (2027-2032) Table 24. Global Sotalol Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sotalol Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sotalol Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sotalol Sales Value Share by Type (2021-2026) Table 28. Global Sotalol Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Sustained Ventricular Tachycardia Table 30. Significant Companies of Atrial Fibrillation/Flutter Table 31. Global Sotalol Sales Volume by Application 2021 VS 2025 VS 2032 (m units) Table 32. Global Sotalol Sales Volume by Application (2021-2026) & (m units) Table 33. Global Sotalol Sales Volume by Application (2027-2032) & (m units) Table 34. Global Sotalol Sales Volume Share by Application (2021-2026) Table 35. Global Sotalol Sales Volume Share by Application (2027-2032) Table 36. Global Sotalol Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Sotalol Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Sotalol Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Sotalol Sales Value Share by Application (2021-2026) Table 40. Global Sotalol Sales Value Share by Application (2027-2032) Table 41. Global Sotalol Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 42. Global Sotalol Sales by Region (2021-2026) & (m units) Table 43. Global Sotalol Sales Market Share by Region (2021-2026) Table 44. Global Sotalol Sales by Region (2027-2032) & (m units) Table 45. Global Sotalol Sales Market Share by Region (2027-2032) Table 46. Global Sotalol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Sotalol Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Sotalol Sales Value Share by Region (2021-2026) Table 49. Global Sotalol Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Sotalol Sales Value Share by Region (2027-2032) Table 51. Global Sotalol Market Average Price (US$/k unit) by Region (2021-2026) Table 52. Global Sotalol Market Average Price (US$/k unit) by Region (2027-2032) Table 53. Global Sotalol Sales by Country: 2021 VS 2025 VS 2032 (m units) Table 54. Global Sotalol Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Sotalol Sales by Country (2021-2026) & (m units) Table 56. Global Sotalol Sales Market Share by Country (2021-2026) Table 57. Global Sotalol Sales by Country (2027-2032) & (m units) Table 58. Global Sotalol Sales Market Share by Country (2027-2032) Table 59. Global Sotalol Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Sotalol Sales Value Market Share by Country (2021-2026) Table 61. Global Sotalol Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Sotalol Sales Value Market Share by Country (2027-2032) Table 63. Shaanxi Hanjiang Pharmaceutical Group Company Information Table 64. Shaanxi Hanjiang Pharmaceutical Group Business Overview Table 65. Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 66. Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio Table 67. Shaanxi Hanjiang Pharmaceutical Group Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 71. GSK Sotalol Product Portfolio Table 72. GSK Recent Development Table 73. Bayer Company Information Table 74. Bayer Business Overview Table 75. Bayer Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 76. Bayer Sotalol Product Portfolio Table 77. Bayer Recent Development Table 78. Samarth Pharma Pvt. Ltd. Company Information Table 79. Samarth Pharma Pvt. Ltd. Business Overview Table 80. Samarth Pharma Pvt. Ltd. Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 81. Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio Table 82. Samarth Pharma Pvt. Ltd. Recent Development Table 83. Cipla Limited Company Information Table 84. Cipla Limited Business Overview Table 85. Cipla Limited Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 86. Cipla Limited Sotalol Product Portfolio Table 87. Cipla Limited Recent Development Table 88. Cambrex Company Information Table 89. Cambrex Business Overview Table 90. Cambrex Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 91. Cambrex Sotalol Product Portfolio Table 92. Cambrex Recent Development Table 93. Bristol-Myers Squibb (BMS) Company Information Table 94. Bristol-Myers Squibb (BMS) Business Overview Table 95. Bristol-Myers Squibb (BMS) Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 96. Bristol-Myers Squibb (BMS) Sotalol Product Portfolio Table 97. Bristol-Myers Squibb (BMS) Recent Development Table 98. Arevipharma Company Information Table 99. Arevipharma Business Overview Table 100. Arevipharma Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 101. Arevipharma Sotalol Product Portfolio Table 102. Arevipharma Recent Development Table 103. Arbor Pharmaceuticals Company Information Table 104. Arbor Pharmaceuticals Business Overview Table 105. Arbor Pharmaceuticals Sotalol Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 106. Arbor Pharmaceuticals Sotalol Product Portfolio Table 107. Arbor Pharmaceuticals Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Sotalol Distributors List Table 111. Sotalol Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Sotalol Product Image Figure 2. Global Sotalol Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sotalol Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sotalol Sales (2021-2032) & (m units) Figure 5. Global Sotalol Sales Average Price (US$/k unit) & (2021-2032) Figure 6. Global Sotalol Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 40mg Sotalol Image Figure 10. 80mg Sotalol Image Figure 11. Global Sotalol Sales Volume by Type (2021 VS 2025 VS 2032) & (m units) Figure 12. Global Sotalol Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sotalol Sales Volume Share by Type (2021-2032) Figure 14. Global Sotalol Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sotalol Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sotalol Sales Value Share by Type (2021-2032) Figure 17. Sustained Ventricular Tachycardia Image Figure 18. Atrial Fibrillation/Flutter Image Figure 19. Global Sotalol Sales Volume by Application (2021 VS 2025 VS 2032) & (m units) Figure 20. Global Sotalol Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Sotalol Sales Volume Share by Application (2021-2032) Figure 22. Global Sotalol Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Sotalol Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Sotalol Sales Value Share by Application (2021-2032) Figure 25. Global Sotalol Sales by Region: 2021 VS 2025 VS 2032 (m units) Figure 26. Global Sotalol Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Sotalol Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Sotalol Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Sotalol Sales Value (2021-2032) & (US$ Million) Figure 30. North America Sotalol Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Sotalol Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Sotalol Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Sotalol Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Sotalol Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Sotalol Sales Value (2021-2032) & (US$ Million) Figure 36. South America Sotalol Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Sotalol Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Sotalol Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Sotalol Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Sotalol Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Sotalol Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Sotalol Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Sotalol Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg Sotalol
  • 80mg Sotalol
Applications
  • Sustained Ventricular Tachycardia
  • Atrial Fibrillation/Flutter
Companies covered
  • Shaanxi Hanjiang Pharmaceutical Group
  • GSK
  • Bayer
  • Samarth Pharma Pvt. Ltd.
  • Cipla Limited
  • Cambrex
  • Bristol-Myers Squibb (BMS)
  • Arevipharma
  • Arbor Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sotalol Sales Value (2021-2032)
  4. 1.2.2 Global Sotalol Sales Volume (2021-2032)
  5. 1.2.3 Global Sotalol Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sotalol Market Dynamics
  1. 2.1 Sotalol Industry Trends
  2. 2.2 Sotalol Industry Drivers
  3. 2.3 Sotalol Industry Opportunities and Challenges
  4. 2.4 Sotalol Industry Restraints
3 Sotalol Market by Company
  1. 3.1 Global Sotalol Company Revenue Ranking in 2025
  2. 3.2 Global Sotalol Revenue by Company (2021-2026)
  3. 3.3 Global Sotalol Sales Volume by Company (2021-2026)
  4. 3.4 Global Sotalol Average Price by Company (2021-2026)
  5. 3.5 Global Sotalol Company Ranking (2024-2026)
  6. 3.6 Global Sotalol Company Manufacturing Base and Headquarters
  7. 3.7 Global Sotalol Company Product Type and Application
  8. 3.8 Global Sotalol Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sotalol Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sotalol Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sotalol Market by Type
  1. 4.1 Sotalol Type Introduction
  2. 4.1.1 40mg Sotalol
  3. 4.1.2 80mg Sotalol
  4. 4.2 Global Sotalol Sales Volume by Type
  5. 4.2.1 Global Sotalol Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sotalol Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sotalol Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sotalol Sales Value by Type
  9. 4.3.1 Global Sotalol Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sotalol Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sotalol Sales Value Share by Type (2021-2032)
5 Sotalol Market by Application
  1. 5.1 Sotalol Application Introduction
  2. 5.1.1 Sustained Ventricular Tachycardia
  3. 5.1.2 Atrial Fibrillation/Flutter
  4. 5.2 Global Sotalol Sales Volume by Application
  5. 5.2.1 Global Sotalol Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sotalol Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sotalol Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sotalol Sales Value by Application
  9. 5.3.1 Global Sotalol Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sotalol Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sotalol Sales Value Share by Application (2021-2032)
6 Sotalol Regional Sales and Value Analysis
  1. 6.1 Global Sotalol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sotalol Sales by Region (2021-2032)
  3. 6.2.1 Global Sotalol Sales by Region: 2021-2026
  4. 6.2.2 Global Sotalol Sales by Region (2027-2032)
  5. 6.3 Global Sotalol Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sotalol Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sotalol Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sotalol Sales Value by Region (2027-2032)
  9. 6.5 Global Sotalol Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sotalol Sales Value (2021-2032)
  12. 6.6.2 North America Sotalol Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sotalol Sales Value (2021-2032)
  15. 6.7.2 Europe Sotalol Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sotalol Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sotalol Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sotalol Sales Value (2021-2032)
  21. 6.9.2 South America Sotalol Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sotalol Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sotalol Sales Value Share by Country, 2025 VS 2032
7 Sotalol Country-level Sales and Value Analysis
  1. 7.1 Global Sotalol Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sotalol Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sotalol Sales by Country (2021-2032)
  4. 7.3.1 Global Sotalol Sales by Country (2021-2026)
  5. 7.3.2 Global Sotalol Sales by Country (2027-2032)
  6. 7.4 Global Sotalol Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sotalol Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sotalol Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sotalol Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sotalol Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sotalol Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sotalol Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sotalol Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sotalol Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sotalol Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sotalol Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sotalol Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sotalol Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sotalol Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sotalol Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sotalol Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sotalol Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sotalol Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sotalol Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sotalol Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sotalol Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sotalol Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sotalol Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sotalol Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sotalol Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sotalol Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sotalol Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sotalol Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sotalol Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sotalol Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sotalol Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sotalol Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sotalol Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sotalol Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sotalol Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sotalol Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sotalol Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sotalol Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sotalol Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sotalol Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sotalol Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sotalol Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sotalol Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sotalol Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sotalol Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sotalol Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sotalol Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sotalol Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sotalol Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sotalol Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sotalol Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sotalol Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sotalol Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sotalol Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sotalol Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sotalol Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sotalol Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sotalol Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sotalol Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sotalol Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sotalol Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sotalol Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sotalol Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sotalol Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sotalol Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sotalol Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sotalol Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sotalol Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sotalol Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sotalol Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sotalol Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sotalol Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sotalol Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sotalol Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sotalol Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sotalol Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sotalol Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sotalol Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sotalol Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sotalol Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sotalol Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sotalol Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sotalol Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sotalol Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sotalol Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sotalol Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sotalol Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shaanxi Hanjiang Pharmaceutical Group
  2. 8.1.1 Shaanxi Hanjiang Pharmaceutical Group Company Information
  3. 8.1.2 Shaanxi Hanjiang Pharmaceutical Group Business Overview
  4. 8.1.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio
  6. 8.1.5 Shaanxi Hanjiang Pharmaceutical Group Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Sotalol Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GSK Sotalol Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Sotalol Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Sotalol Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Samarth Pharma Pvt. Ltd.
  20. 8.4.1 Samarth Pharma Pvt. Ltd. Company Information
  21. 8.4.2 Samarth Pharma Pvt. Ltd. Business Overview
  22. 8.4.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio
  24. 8.4.5 Samarth Pharma Pvt. Ltd. Recent Developments
  25. 8.5 Cipla Limited
  26. 8.5.1 Cipla Limited Company Information
  27. 8.5.2 Cipla Limited Business Overview
  28. 8.5.3 Cipla Limited Sotalol Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cipla Limited Sotalol Product Portfolio
  30. 8.5.5 Cipla Limited Recent Developments
  31. 8.6 Cambrex
  32. 8.6.1 Cambrex Company Information
  33. 8.6.2 Cambrex Business Overview
  34. 8.6.3 Cambrex Sotalol Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cambrex Sotalol Product Portfolio
  36. 8.6.5 Cambrex Recent Developments
  37. 8.7 Bristol-Myers Squibb (BMS)
  38. 8.7.1 Bristol-Myers Squibb (BMS) Company Information
  39. 8.7.2 Bristol-Myers Squibb (BMS) Business Overview
  40. 8.7.3 Bristol-Myers Squibb (BMS) Sotalol Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bristol-Myers Squibb (BMS) Sotalol Product Portfolio
  42. 8.7.5 Bristol-Myers Squibb (BMS) Recent Developments
  43. 8.8 Arevipharma
  44. 8.8.1 Arevipharma Company Information
  45. 8.8.2 Arevipharma Business Overview
  46. 8.8.3 Arevipharma Sotalol Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Arevipharma Sotalol Product Portfolio
  48. 8.8.5 Arevipharma Recent Developments
  49. 8.9 Arbor Pharmaceuticals
  50. 8.9.1 Arbor Pharmaceuticals Company Information
  51. 8.9.2 Arbor Pharmaceuticals Business Overview
  52. 8.9.3 Arbor Pharmaceuticals Sotalol Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Arbor Pharmaceuticals Sotalol Product Portfolio
  54. 8.9.5 Arbor Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sotalol Value Chain Analysis
  2. 9.1.1 Sotalol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sotalol Sales Mode & Process
  6. 9.2 Sotalol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sotalol Distributors
  9. 9.2.3 Sotalol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst